| Class 530 | CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF |
| Click here for a printable version of this file | |
Expand/Contract Processing Please Wait
| This Class 530 is considered to be an integral part of Class 260 (see the Class 260 schedule for the position of this Class in schedule hierarchy). This Class retains all pertinent definitions and class lines of Class 260. | ||
![[List of Pre Grant Publications for class 530 subclass 200]](../as.gif) | ![[List of Patents for class 530 subclass 200]](../ps.gif) | 200 | NATURAL RESINS OR DERIVATIVES (E.G., WOOD OR PINE TAR; CATIVO RESIN DERIVATIVES, ETC.) |
| | 201 |  Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.) |
| | 202 | Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material) |
| | 203 | Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material) |
| | 204 |  Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material) |
| | 206 | Organic sulfur or nitrogen containing material used in the process, or product thereof |
| | 207 | Esterification used in the process, or product thereof |
| | 208 | Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.) |
| | 210 | Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.) |
| | 211 | Polymerization or product thereof (e.g., dimer rosin, etc.) |
| | 213 | Boron or phosphorus containing material used in the process, or product thereof |
| | 214 | Diels-Alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.) |
| | 215 | Esterification of rosin or derivative via carboxyl group, or product thereof |
| | 217 |  Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.) |
| | 218 | Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.) |
| | 219 | Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.) |
| | 221 | Nitrogen containing material used in the process, or product thereof |
| | 223 | Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.) |
| | 224 | Metal containing material used to form salts of rosin acids, or product thereof |
| | 226 | Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.) |
| | 227 | Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.) |
| | 228 | Purification process or product thereof |
| | 230 | Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.) |
| | 300 | PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES |
| | 301 | Thymopoietin or Lipotropin; related peptides |
| | 302 | Endorphin and Enkephalin; related peptides |
| | 303 | Insulin; related peptides |
| | 306 | Corticotropin (ATCH); related peptides |
| | 307 | Calcitonin; related peptides |
| | 308 | Glucagon; related peptides |
| | 309 | Secretin or gastrin; related peptides |
| | 310 | Gramicidin or Tyrocidin; related peptides |
| | 311 | Somatostatin (SRIF); related peptides |
| | 312 | Melanotropin (MSH) or eledoisin; related peptides |
| | 313 | Lutenizing hormone releasing factor (LRF); related peptides |
| | 314 | Bradykinin; kallidin; related peptides |
| | 315 | Oxytocin; vasopressin; related peptides |
| | 316 | Angiotensin; related peptides |
| | 317 | Cyclic peptides |
| | 318 | The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid |
| | 320 | Bacitracin; related peptides |
| | 321 | Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides |
| | 322 | Peptides containing saccharide radicals, e.g., bleomycins, etc. |
| | 324 | 25 or more amino acid residues in defined sequence |
| | 325 | 24 amino acid residues in defined sequence |
| | 326 | 15 to 23 amino acid residues in defined sequence |
| | 327 | 11 to 14 amino acid residues in defined sequence |
| | 328 | 8 to 10 amino acid residues in defined sequence |
| | 329 | 6 to 7 amino acid residues in defined sequence |
| | 330 | 4 to 5 amino acid residues in defined sequence |
| | 331 | Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc. |
| | 332 | Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc. |
| | 333 | Synthesis of peptides |
| | 334 | Polymer supported synthesis, e.g., solid phase synthesis, Merrifield synthesis, etc. |
| | 335 | Protecting or removing protective groups, e.g., carboxyl group protection, etc. |
| | 338 | Solution phase synthesis |
| | 339 | Segment condensation, e.g., Ugi condensation, etc. |
| | 340 | With phosphorus containing material |
| | 341 | With use of carbonimide or imidiazole |
| | 342 | Mixed anhydride synthesis |
| | 343 | By hydrolysis |
| | 344 | Separation or purification |
| | 345 | Chemical aftertreatment, e.g., acylation, methylation, etc. |
| | 350 | PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES |
| | 351 | Lymphokines, e.g., interferons, interlukins, etc. |
| | 352 | Phosphoproteins, e.g., phosvitin, vitellogenin, etc. |
| | 353 | Scleroproteins, e.g., fibroin, elastin, silk, etc. |
| | 358 | Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc. |
| | 359 | Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc. |
| | 360 | Casein or caseinate |
| | 362 | Albumin |
| | 363 | Serum albumin, e.g., BSA, HSA, etc. |
| | 365 | Lactalbumin, e.g., milk source, etc. |
| | 367 | Ovalalbumin, e.g., avidin, conalbumins, etc. |
| | 369 | Separation, purification or synthesis |
| | 370 | Plant proteins, e.g., derived from legumes, algae or lichens, etc. |
| | 371 | Derived from fungi, e.g., yeasts, mushroom, etc. |
| | 372 | Derived from grain, e.g., prolamines, etc. |
| | 377 | Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc. |
| | 379 | Derived from leafy green plants, e.g., alfalfa pollen, etc. |
| | 380 | Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. |
| | 381 | Blood coagulation factors and fibrin, e.g., thromboplastin, etc. |
| | 382 | Fibrin or fibrin intermediates, e.g., fibrinogen, etc. |
| | 383 | Blood coagulation factor VIII, AHF |
| | 384 | Blood coagulation factor II or factor II + VII + IX + X, i.e., prothrombin complex or factor |
| | 385 | Hemoglobins or globins |
| | 386 | Globulins |
| | 387.1 | Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or adsorbed |
| | 387.2 |  Anti-idiotypic |
| | 387.3 | Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.) |
| | 387.5 | Binds oligosaccharide structure |
| | 387.7 | Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
| | 387.9 | Binds specifically-identified amino acid sequence |
| | 388.1 | Monoclonal |
| | 388.15 |  Human |
| | 388.2 | Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.) |
| | 388.21 |  Binds nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.) |
| | 388.22 | Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.) |
| | 388.25 | Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
| | 388.26 | Binds enzyme |
| | 388.3 | Binds virus or component or product thereof (e.g., virus-associated antigen, etc.) |
| | 388.4 | Binds bacterium or similar microorganism or component or product thereof (e.g., Stretococcus, Legionella, Mycoplasma, bacterium-associated antigen, exotoxin, etc.) |
| | 388.5 | Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.) |
| | 388.6 | Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.) |
| | 388.8 | Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.) |
| | 388.9 | Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.) |
| | 389.1 | Polyclonal antibody or immunogloblin of identified binding specificity |
| | 389.3 | Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
| | 389.4 | Binds virus or component or product thereof (e.g., virus-associated antigen, etc.) |
| | 389.5 | Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.) |
| | 389.6 | Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.) |
| | 389.7 | Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.) |
| | 389.8 | Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.) |
| | 390.1 | Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.) |
| | 391.1 | Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.) |
| | 391.3 | Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound |
| | 391.5 | Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent |
| | 391.7 | Conjugated to a cytotoxic agent, drug, or other biologically-active substance |
| | 392 | Alpha globulins, e.g., ceruloplastin, haptoglobins, etc. |
| | 394 | Beta globulins, e.g., transferrin, etc. |
| | 395 | Glycoprotein, e.g., mucins, proteoglycans, etc. |
| | 399 | Hormones, e.g., prolactin, thymosin, growth factors, etc. |
| | 400 | Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc. |
| | 402 | Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc. |
| | 403 | Protein is identified as an antigen, e.g., immunogenic carriers, etc. |
| | 407 | Hydrolysis of protein |
| | 408 | Sulfur containing reactant |
| | 409 | Nitrogen containing reactant |
| | 410 | Oxygen containing reactant |
| | 412 | Separation or purification |
| | 413 | Immunological separation or affinity chromatography |
| | 414 | Ultra filtration or osmosis |
| | 415 | Selective absorbtion, e.g., Ca phosphate sorbents, etc. |
| | 416 | Ion exchange |
| | 417 | Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc. |
| | 418 | Precipitation |
| | 422 | Solvent extraction |
| | 427 | Physical treatment |
| | 500 | LIGNINS OR DERIVATIVES |
| | 501 | Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof |
| | 502 | Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof |
| | 503 | Hydrogenation of a lignin or lignin containing substance, or product thereof |
| | 504 | Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof |
| | 505 | Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof |
| | 506 | Heavy metal, aluminum, silicon or phosphorus containing |
| | 507 | Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof |
| CROSS-REFERENCE ART COLLECTIONS | ||
| | 800 | ANTIHYPERTENSIVE PEPTIDES |
| | 801 | PEPTIDE SWEETNERS |
| | 802 | CHROMOGENIC OR LUMINESCENT PEPTIDES |
| | 806 | ANTIGENIC PEPTIDES OR PROTEINS |
| | 807 | HAPTEN CONJUGATED WITH PEPTIDE OR PROTEIN |
| | 808 | MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC. |
| | 810 | CARRIER - BOUND OR IMMOBILIZED PEPTIDES OR PROTEINS AND THE PREPARATION THEREOF, E.G., BIOLOGICAL CELL OR CELL FRAGMENT AS CARRIER, ETC. |
| | 811 | Peptides or proteins is immobilized on, or in, an inorganic carrier |
| | 812 | Peptides or proteins is immobilized on, or in, an organic carrier |
| | 820 | PROTEINS FROM MICRO-ORGANISMS |
| | 821 | Separation of nucleic acid |
| | 822 | Protozoa |
| | 823 | Lower fungi, e.g., mold, etc. |
| | 825 | Bacteria |
| | 826 | Viruses |
| | 827 | PROTEINS FROM MAMMALS OR BIRDS |
| | 828 | Cancer |
| | 829 | Blood |
| | 832 | Milk; colostrum |
| | 833 | Whey; cheese |
| | 834 | Urine; urinary system |
| | 836 | Mucus; mucous glands; bursa; arthral fluid; spinal fluid |
| | 837 | Lymph; lymph-glands; thymus |
| | 838 | Marrow; spleen |
| | 839 | Nerves; brain |
| | 840 | Bones; tendons; teeth; cartilage |
| | 841 | Muscles; heart |
| | 842 | Skin; hair; nails; sebaceous glands; cerumen |
| | 843 | Digestive system |
| | 848 | Lungs |
| | 849 | Eyes; vessels; umbilical cord |
| | 850 | Reproductive organs or embryos |
| | 854 | Glands |
| | 855 | PROTEINS FROM ANIMALS OTHER THAN MAMMALS OR BIRDS |
| | 859 | WASTE, WASTE MATERIAL, REFUSE OR SLUDGE, E.G., EFFLUENTS, FECAL MATTER, ETC. |
| | 860 | RENIN INHIBITORS |
| | 861 | INVOLVING IGG3, IGG4, IGA, OR IGY |
| | 862 | INVOLVING IGE OR IGD |
| | 863 | INVOLVING IGM |
| | 866 | INVOLVING IMMUNOGLOBULIN OR ANTIBODY FRAGMENT, (E.G., F(AB)'2, FAB', FAB, FV, FC, HEAVY CHAIN, LIGHT CHAIN, ETC.) |
| | 867 | INVOLVING IMMUNOGLOBULIN OR ANTIBODY PRODUCED VIA RECOMBINANT DNA TECHNOLOGY |
| | 868 | INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCE |
| FOREIGN ART COLLECTIONS | ||
| FOR000 | CLASS-RELATED FOREIGN DOCUMENTS |